Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Artax Biopharma
1 Broadway, 14th Floor
Cambridge, MA 02142
Phone: 617-368-0676
http://www.artaxbiopharma.com/

Artax Biopharma is a clinical-stage biotechnology company transforming T Cell-mediated disease treatment by developing innovative small molecules that modulate the immune system. Artax science holds broad potential to treat T Cell-mediated diseases such as autoimmune diseases; induced T cell pathologies (such as acute graft-versus-host disease and immune-oncology treatment-related adverse events); and T Cell malignancies, while simultaneously allowing the body to fight foreign pathogens.

Key Contact
Name
Joseph Lobacki
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/11/22 $26,000,000 Advent Life Sciences
Columbus Ventures
Eli Lilly and Company
Sound Bioventures
Termeer Family Office
undisclosed


Featured Reading